Mersana Therapeutics Stock Target Price and Analyst Consensus
| MRSN Stock | USD 29.08 0.18 0.62% |
The current analyst and expert consensus on Mersana Therapeutics is Strong Buy, with 8 strong buy opinions. The current projected Mersana Therapeutics target price consensus is 30.75 with 9 analyst opinions. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. The most common way Mersana Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Mersana Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Mersana Therapeutics. We strongly encourage you to use your own analysis of Mersana Therapeutics to validate this buy or sell advice. Mersana Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Mersana Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 31.2958.
Lowest Forecast 27.98 | Highest Forecast 34.13 | Target Price 30.75 |
It's important to approach Mersana Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Mersana Therapeutics Target Price Consensus
Mersana target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Mersana Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most Mersana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Mersana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Mersana Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMersana Therapeutics Target Price Projection
Mersana Therapeutics' current and average target prices are 29.08 and 30.75, respectively. The current price of Mersana Therapeutics is the price at which Mersana Therapeutics is currently trading. On the other hand, Mersana Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Mersana Therapeutics Market Quote on 29th of January 2026
Target Price
Analyst Consensus On Mersana Therapeutics Target Price
Mersana Therapeutics Analyst Ratings
Mersana Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Mersana Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Mersana Therapeutics' financials, market performance, and future outlook by experienced professionals. Mersana Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Mersana Therapeutics price targets
Mersana Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Mersana Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Mersana Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Mersana Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Mersana Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Mersana Therapeutics is a key component of Mersana Therapeutics valuation and have some predictive power on the future returns of a Mersana Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mersana Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 40 shares | |
 | Dividend Beast Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Adviser Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Climate Change Invested over 90 shares | |
 | Trump Equities Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Impulse Invested few shares | |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.